[Long-term results of combined photon-neutron radiotherapy for malignant salivary gland tumors at the Ural Neutron Therapy Center].
An evaluation of combined photon-neutron radiotherapy (CPNT) of malignant tumors of the salivary gland (31) is presented. Overall 1-year survival was 100%, 2 years--95%, 3 years--65%, 4 years--57% and 5 years--47%. Radiation-related injury incidence did not vary dramatically: CPNT--15%, photon therapy--11%. Most relapse occurred within the first 24 months.